Supreme Court: Non-Signatory Can Be Bound By an Agreement if Involved in Performing the Contract || Supreme Court: 'Washed-Off Theory' Inapplicable in Assessing Employee Retention Suitability || SC Directs States/UTs to Grant Ex-Servicemen Quota to Cadets Disabled 40% or More in Training || Delhi High Court Quashed Cases over Allegations of Excess Lead Content in Maggi Noodles || Madras High Court: Advocates Cannot Hinder Police From Producing Arrested Lawyers Before a Court || Allahabad HC Awarded Rs. 4.75 Lakh Compensation Over Illegal Vehicle Confiscation in a Beef Case || Allahabad High Court: Strong Suspicion, Not Proof of Guilt, is Sufficient to Frame Charges || Delhi HC: Prior Sanction Not Required Where Cognizance Preceded 2018 PC Act Amendment || Bombay High Court: The Notion of a "Perfect Victim" in Rape Cases is a Myth || Allahabad High Court: Prior Agreement With Inquiry Report Doesn't Vitiate Disciplinary Proceedings

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :